- Home
- LTRY vs CYCC Comparison
LTRY vs CYCC Comparison
Compare LTRY & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRY
- CYCC
- Stock Information
- Founded
- LTRY 2015
- CYCC 1992
- Country
- LTRY United States
- CYCC United States
- Employees
- LTRY N/A
- CYCC N/A
- Industry
- LTRY Computer Software: Prepackaged Software
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- LTRY Technology
- CYCC Health Care
- Exchange
- LTRY Nasdaq
- CYCC Nasdaq
- Market Cap
- LTRY 4.4M
- CYCC 3.6M
- IPO Year
- LTRY N/A
- CYCC N/A
- Fundamental
- Price
- LTRY $0.92
- CYCC $0.23
- Analyst Decision
- LTRY
- CYCC Strong Buy
- Analyst Count
- LTRY 0
- CYCC 1
- Target Price
- LTRY N/A
- CYCC $11.00
- AVG Volume (30 Days)
- LTRY 648.2K
- CYCC 161.7K
- Earning Date
- LTRY 05-19-2025
- CYCC 05-13-2025
- Dividend Yield
- LTRY N/A
- CYCC N/A
- EPS Growth
- LTRY N/A
- CYCC N/A
- EPS
- LTRY N/A
- CYCC N/A
- Revenue
- LTRY $6,143,350.00
- CYCC $43,000.00
- Revenue This Year
- LTRY N/A
- CYCC N/A
- Revenue Next Year
- LTRY N/A
- CYCC $88.68
- P/E Ratio
- LTRY N/A
- CYCC N/A
- Revenue Growth
- LTRY 190.77
- CYCC N/A
- 52 Week Low
- LTRY $0.22
- CYCC $0.22
- 52 Week High
- LTRY $2.39
- CYCC $4.00
- Technical
- Relative Strength Index (RSI)
- LTRY 43.71
- CYCC 26.52
- Support Level
- LTRY $0.83
- CYCC $0.22
- Resistance Level
- LTRY $1.00
- CYCC $0.32
- Average True Range (ATR)
- LTRY 0.14
- CYCC 0.02
- MACD
- LTRY -0.02
- CYCC -0.01
- Stochastic Oscillator
- LTRY 27.27
- CYCC 9.09
About LTRY Lottery.com Inc.
Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.